Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole.

Klein, K O; Demers, L M; Santner, S J; Baron, J; Cutler, G B; Santen, R J

Klein, K O; Demers, L M; Santner, S J; Baron, J; Cutler, G B; Santen, R J.

Affiliation

Klein KO; Children's Hospital of Orange County, California 92668, USA.

J Clin Endocrinol Metab ; 80(9): 2658-60, 1995 Sep.

Article in En | MEDLINE | ID: mdl-7673408

Subject(s)

Aromatase Inhibitors; Biological Assay/methods; Breast Neoplasms/blood; Breast Neoplasms/drug therapy; Estradiol/blood; Nitriles/therapeutic use; Triazoles/therapeutic use; Female; Humans; Letrozole; Radioimmunoassay; Recombination, Genetic; Sensitivity and Specificity

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Triazoles / Biological Assay / Breast Neoplasms / Aromatase Inhibitors / Estradiol / Nitriles Type of study: Diagnostic_studies Limits: Female / Humans Language: En Journal: J Clin Endocrinol Metab Year: 1995 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links